![MLN8237 (Alisertib) - Aurora A inhibitor. CAS# 1028486-01-2 60125 5-dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/xcessbio1409715053.7305935.png?v=1742651489)
Pay in 4 interest-free payments of $14.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
5-dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine
(2012) Nature Methods 9(6)
RaH3 and RaH5
17(2):261-6
Chem Pharm Bull (Tokyo)
MLN8237 (Alisertib) - Aurora A inhibitor. CAS# 1028486-01-2 60125 5-dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholineMLN8237 (Alisertib), CAS No. 1028486 01 2, is a highly potent and selective Aurora A inhibitor with an IC50 of 1. 2 nM, >200 fold selective towards structurally related Aurora B (IC50 of 396. 5 nM). It does not have any significant activity against 205 other kinases. MLN8237 treatment inhibits the phosphorylation of Aurora A in MM1. S and OPM1 cells, without affecting the Aurora B mediated histone H3 phosphorylation. MLN8237 significantly inhibits
US$ 250.00
US$ 350.00
US$ 500.00
US$ 14.99
US$ 2400.00
US$ 850.00
US$ 4125.00
US$ 300.00
US$ 750.00
US$ 6375.00